Ion Beam Applications (IBA) of Louvain-la-Neuve, Belgium, announced a collaboration with ARCHADE, a regional healthcare association, to develop a prototype system for hadron (subatomic particle) therapy in Caen, France.
The preliminary agreement is intended to qualify equipment that will be used to administer particle-beam radiation therapy by 2011, using carbon ions as well as protons in the treatment of specific radio-resistant tumors.
An investment of 40 million euros ($57.9 million) will be available for the development phase of the project.
Related Reading
IBA finalizes proton therapy deal, December 21, 2007
FDA OKs Compass dosimetry device, December 18, 2007
IBA sells cyclotron to Saudi Arabia, December 4, 2007
IBA, PETLinQ acquire SourceMedical's radiology division, November 26, 2007
IBA to acquire full interest in CIS Bio, September 14, 2007
Copyright © 2008 AuntMinnie.com
